Challenger (CGF) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
11 Dec, 2025Executive summary
Delivered strong 1H25 performance with double-digit growth in earnings, EPS, and dividends, and ROE above target, supported by strategic execution, cost base reset, and technology investment.
Achieved record retail lifetime and Japanese annuity sales, driven by expanded advisor network, product innovation, and new partnerships.
Significant investments in customer and investment technology platforms, including upgrades and new partnerships, to drive future growth and operational efficiency.
Strengthened capital position and increased interim dividend by 12% to 14.5cps, with payout ratio at 44%.
Group assets under management reached $131bn, up 12% year-over-year.
Financial highlights
Normalised NPAT rose 12% year-over-year to AUD 225 million; statutory NPAT up 28% to AUD 72 million.
Normalised EPS rose 12% to 32.8cps; statutory EPS was 10.5c, up from 8.2c.
Interim dividend increased 12% to 14.5cps per share.
Group ROE post-tax reached 11.6%, up 120bps, exceeding target for the first time since 2017.
Funds Management NPAT increased 37% to $27m; FUM grew 12.5% to $121bn despite net outflows.
Outlook and guidance
On track to meet FY25 normalised NPAT guidance of AUD 440–480 million, with midpoint 10% higher than FY24.
Targeting a dividend payout ratio of 30%-50% and maintaining a strong PCA ratio within the 1.3x–1.7x range.
Continued focus on long-term sustainable growth, post-tax metrics, and further operating leverage.
Latest events from Challenger
- Statutory NPAT up 369% to AUD 339m, with record annuity sales and strong capital position.CGF
H1 202617 Feb 2026 - Record normalized profit, higher ROE, and strong capital set up for further growth in FY25.CGF
H2 20242 Feb 2026 - Profit and assets rose 17% and 21%, dividend up 10%, board and ESG progress made.CGF
AGM 202419 Jan 2026 - APRA's capital reforms boost resilience, lower volatility, and support growth in annuity products.CGF
Investor Update6 Jan 2026 - Earnings and EPS up 9%, record annuity sales, and strong capital discipline support growth.CGF
H2 202523 Nov 2025 - Strong financials, Board renewal, and digital focus drive optimism for future growth.CGF
AGM 202530 Oct 2025